Erin S Morgan Selected Research

IONIS-PTP-1BRx

1/2018

Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1BRx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin S Morgan Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 03/2015
1	Hypertension (High Blood Pressure) 06/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Insulin Resistance 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Overweight 01/2018

Drug/Important Bio-Agent (IBA)

2	Antisense OligonucleotidesIBA 01/2019 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2021
1	Angiotensin Receptor AntagonistsIBA 06/2021
1	LDL CholesterolIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2019
1	Liver GlycogenIBA 01/2019
1	N 30IBA 01/2018
1	IONIS-PTP-1BRxIBA 01/2018
1	AdiponectinIBA 01/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	LeptinIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	Glucagon (Glukagon)FDA Link 03/2015

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2018
1	Subcutaneous Injections 01/2019